Skip to main content

Want a detailed portfolio tracker?

Comparison Cogent Biosciences (COGT) with Competitors

Cogent Biosciences (COGT) industry is Biotechnology.

Debt-to-Equity
COGT36.72%
Industry28.27%
Upside+29.91%
Free Cash Flow Yield
COGT-4.27%
Industry-1.75%
Upside-2.52%
P/E
COGT-16.17
Industry-20.52
Upside+435.06%
P/S
COGT861.15
Industry10.01
Upside+8499.86%
P/B
COGT12.13
Industry5.15
Upside+135.68%